Skip to main content

Common Dreams. Journalism funded by people, not corporations.

There has never been—and never will be—an advertisement on our site except for this one: without readers like you supporting our work, we wouldn't exist.

No corporate influence. No pay-wall. Independent news and opinion 365 days a year that is freely available to all and funded by those who support our mission: To inform. To inspire. To ignite change for the common good.

Our mission is clear. Our model is simple. If you can, please support our Fall Campaign today.

Support Our Work -- No corporate influence. No pay-wall. Independent news funded by those who support our mission: To inform. To inspire. To ignite change for the common good. Please support our Fall Campaign today.

Liesl Eibschutz, a medical student from Dartmouth University, loads a syringe with Pfizer COVID-19 vaccine at Kedren Health on Thursday, April 15, 2021 in Los Angeles, CA. (Photo: Allen J. Schaben/Los Angeles Times via Getty Images)

Liesl Eibschutz, a medical student from Dartmouth University, loads a syringe with the Pfizer Covid-19 vaccine at Kedren Health in Los Angeles, California on April 15, 2021. (Photo: Allen J. Schaben/Los Angeles Times via Getty Images)

FDA Panel Recommends Pfizer Booster Shots for People 65+ and Especially Vulnerable

The scientific advisory committee voted down a recommendation for other adults.

Common Dreams staff

A Food and Drug Administration advisory panel on Friday unanimously recommended booster shots of the Pfizer Covid-19 vaccine for U.S. adults age 65 and older, and those especially at risk from virus, while voting strongly against recommending the same for people between the ages of 16 and 64.  

Though neither vote is binding, the agency is likely to follow the advice of the 18-member committee and is expected to issue a final decision on boosters—a topic of controversy in recent months, especially given the ongoing global inequity in terms of access to vaccines—as early as next week.

According to the Associated Press:

The decision was made by a committee of outside experts who advise the Food and Drug Administration.

In a surprising turn, the panel first rejected, by a vote of 16-2, boosters for nearly everyone.

Members cited a lack of safety data on extra doses and also raised doubts about the value of mass boosters, rather than ones targeted to specific groups. Then, in an 18-0 vote, it endorsed the extra shot for select portions of the U.S. population—namely, those most at risk from the virus.

While the Biden administration had set a public goal of enacting a booster program for all U.S. adults this fall, there has been consistent pushback from the scientific community over whether the evidence supported the need for such a sweeping policy.

"It's unclear that everyone needs to be boosted, other than a subset of the population that clearly would be at high risk for serious disease," Dr. Michael G. Kurilla, a committee member and official at the National Institutes of Health, told the New York Times.

Dr. Ashish Jha, the dean of the Brown University School of Public Health, welcomed the panel's position, tweeting Friday that it is "clearly consistent with the evidence and this outcome should never have been in doubt."


Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.

This is the world we live in. This is the world we cover.

Because of people like you, another world is possible. There are many battles to be won, but we will battle them together—all of us. Common Dreams is not your normal news site. We don't survive on clicks. We don't want advertising dollars. We want the world to be a better place. But we can't do it alone. It doesn't work that way. We need you. If you can help today—because every gift of every size matters—please do. Without Your Support We Simply Don't Exist.

'The Facebook Papers' Spur More Calls to 'Break Them Up!'

Other critics are demanding a "full, independent, outside investigation" of the tech titan as whistleblower Frances Haugen testifies to the U.K. Parliament.

Jessica Corbett ·


Critics See Menendez Villainy Equal to Sinema's on Medicare Drug Pricing Fight

"It's discouraging to see Sen. Menendez is on the wrong side of this fight rather than leading the charge for more affordable, accessible healthcare for all."

Brett Wilkins ·


Humanity 'Way Off Track': WMO Says Atmospheric Carbon at Level Unseen in 3 Million Years

The new report has "a stark, scientific message for climate change negotiators at COP 26," said the head of the World Meteorological Organization.

Andrea Germanos ·


Any Lawmaker Involved in Planning Jan. 6 Insurrection 'Must Be Expelled,' Says AOC

Organizers of the deadly assault on the U.S. Capitol say that several congressional Republicans and White House officials helped plan former President Donald Trump's coup attempt.

Kenny Stancil ·


Profits Before People: 'The Facebook Papers' Expose Tech Giant Greed

"This industry is rotten at its core," said one critic, "and the clearest proof of that is what it's doing to our children."

Jon Queally ·

Support our work.

We are independent, non-profit, advertising-free and 100% reader supported.

Subscribe to our newsletter.

Quality journalism. Progressive values.
Direct to your inbox.

Subscribe to our Newsletter.


Common Dreams, Inc. Founded 1997. Registered 501(c3) Non-Profit | Privacy Policy
Common Dreams Logo